Software Tool for Brain Connectivity Analysis

Structural magnetic resonance imaging (MRI) is a constitutive part of the clinical assessment of neurodegenerative patients. The routine neuroimaging evaluation of structural markers from preclinical to conspicuous stage is a key figure of how the disease is conceptualized, and will determine its...

Full description

Saved in:
Bibliographic Details
Main Author: Gan, Heng Yi
Format: Final Year Project
Language:English
Published: Universiti Teknologi PETRONAS 2017
Subjects:
Online Access:http://utpedia.utp.edu.my/22978/1/GanHengYi_18190_dissertation.pdf
http://utpedia.utp.edu.my/22978/
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Structural magnetic resonance imaging (MRI) is a constitutive part of the clinical assessment of neurodegenerative patients. The routine neuroimaging evaluation of structural markers from preclinical to conspicuous stage is a key figure of how the disease is conceptualized, and will determine its imminent diagnosis and treatment to dementia. Atrophy, a late feature in the progression of the disease, is now a valid diagnostic marker to the neurodegenerative diseases. At the mild cognitive impairment stage of the Alzheimer disease (AD), the valid diagnostic marker is the atrophy of medical temporal structure [33]. In temporal lobe epilepsy (TLE), the atrophy of the subcortical brain structures specifically the size of the hippocampus is observed [34]. Apart from these neurodegenerative diseases, there is a significant evidence showing that the long-term ‘Ketum’ drug abuse also causes dementia which are profound impairments of learning and memory. These cognitive-impairing effects are revealed by the analysis of electroencephalogram (EEG) that shows a significant decline of delta power in the hippocampus [35]. Additionally, in the electrocorticography (ECoG) of the frontal cortex, it is found out that there is a complete suppression of the delta and theta bands [35].